Feng Ye

Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China

Ruchong Chen, Wenhua Liang, Mei Jiang et al. · CHEST Journal · 2020 · 692 citations · Full text

Public Health, Biostatistics, Infectious Diseases +16

Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis

Wei‐jie Guan, Wenhua Liang, Yi Zhao et al. · medRxiv · 2020 · 650 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +17

circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast Cancer

Feng Ye, Guanfeng Gao, Yutian Zou et al. · Molecular Therapy — Nucleic Acids · 2019 · 260 citations · Full text

Medicine, Cancer Biology, Oncology +16

Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial

Shun Lü, Lin Wu, Hong Jian et al. · The Lancet Oncology · 2022 · 243 citations

Medicine, Oncology, Pharmacology +17

miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer

Peng Liu, Hailin Tang, Bo Chen et al. · Cancer Letters · 2014 · 120 citations

Medicine, Cancer Biology, Oncology +14